Meeting the challenges in the management of venous thromboembolism. Oral direct thrombin inhibition: a new conceptWEITZ, Jeffrey.Drugs (Basel). 2004, Vol 64, issn 0012-6667, 57 p., SUP1Serial Issue

Emerging anticoagulants for the treatment of venous thromboembolism : Traitement of venous thromboembolismWEITZ, Jeffrey I.Thrombosis and haemostasis. 2006, Vol 96, Num 3, pp 274-284, issn 0340-6245, 11 p.Article

New oral anticoagulants in developmentWEITZ, Jeffrey I.Thrombosis and haemostasis. 2010, Vol 103, Num 1, pp 62-70, issn 0340-6245, 9 p.Article

Emerging anticoagulant drugsWEITZ, Jeffrey I.Arteriosclerosis, thrombosis, and vascular biology. 2007, Vol 27, Num 4, pp 721-721, issn 1079-5642, 1 p.Article

New approaches to oral anticoagulation: Direct thrombin inhibitorsWEITZ, Jeffrey I.Thrombosis and haemostasis. 2009, Vol JUN, pp 11-15, issn 0340-6245, 5 p., HSConference Paper

Treatment of venous thromboembolism and long-term prevention of recurrence: Present treatment options and XimelagatranERIKSSON, Henry.Drugs (Basel). 2004, Vol 64, pp 37-46, issn 0012-6667, 10 p., SUP1Article

Clinical potential of oral direct thrombin inhibitors in the prevention and treatment of venous thromboembolismAGNELLI, Giancarlo.Drugs (Basel). 2004, Vol 64, pp 47-52, issn 0012-6667, 6 p., SUP1Article

Clinical experience with Ximelagatran in Orthopaedic SurgeryERIKSSON, Bengt.Drugs (Basel). 2004, Vol 64, pp 27-35, issn 0012-6667, 9 p., SUP1Article

Direct thrombin inhibitorsWEITZ, Jeffrey I; CROWTHER, Mark.Thrombosis research. 2002, Vol 106, Num 3, pp V275-V284, issn 0049-3848Article

New anticoagulant drugsWEITZ, Jeffrey I; HIRSH, Jack.Chest. 2001, Vol 119, Num 1, pp 95S-107S, issn 0012-3692, SUPArticle

Oral direct thrombin inhibition: an effective and novel approach for venous thromboembolismHAAS, Sylvia.Drugs (Basel). 2004, Vol 64, pp 7-16, issn 0012-6667, 10 p., SUP1Article

Orthopaedic surgery as a model for drug development in thrombosisDAHL, Ola E.Drugs (Basel). 2004, Vol 64, pp 17-25, issn 0012-6667, 9 p., SUP1Article

The status of new anticoagulantsBATES, Shannon M; WEITZ, Jeffrey I.British journal of haematology. 2006, Vol 134, Num 1, pp 3-19, issn 0007-1048, 17 p.Article

New anticoagulantsHIRSH, Jack; O'DONNELL, Martin; WEITZ, Jeffrey I et al.Blood. 2005, Vol 105, Num 2, pp 453-463, issn 0006-4971, 11 p.Article

Emerging anticoagulant drugsBATES, Shannon M; WEITZ, Jeffrey I.Arteriosclerosis, thrombosis, and vascular biology. 2003, Vol 23, Num 9, pp 1491-1500, issn 1079-5642, 10 p.Article

Direct thrombin inhibitors in acute coronary syndromes: Present and futureWEITZ, Jeffrey I; BULLER, Harry R.Circulation (New York, N.Y.). 2002, Vol 105, Num 8, pp 1004-1011, issn 0009-7322Article

Leukocyte urokinase plasminogen activator receptor and PSGL I play a role in endogenous arterial fibrinolysisXUFANG BAI; WEITZ, Jeffrey I; GROSS, Peter L et al.Thrombosis and haemostasis. 2009, Vol 102, Num 6, pp 1212-1218, issn 0340-6245, 7 p.Article

New Antithrombotic Drugs : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)WEITZ, Jeffrey I; HIRSH, Jack; SAMAMA, Meyer M et al.Chest. 2008, Vol 133, Num 6, issn 0012-3692, 234.S-256.S, SUPArticle

New anticoagulants : beyond heparin, low-molecular-weight heparin and warfarinBATES, Shannon M; WEITZ, Jeffrey I.British journal of pharmacology. 2005, Vol 144, Num 8, pp 1017-1028, issn 0007-1188, 12 p.Article

Pharmacology and clinical potential of direct thrombin inhibitors : Novel factor Xa-and thrombin-inhibitorsLINKINS, Lori-Ann; WEITZ, Jeffrey I.Current pharmaceutical design. 2005, Vol 11, Num 30, pp 3877-3884, issn 1381-6128, 8 p.Article

Current options in the prevention of thromboembolic diseaseANSELL, Jack; BERGQVIST, David.Drugs (Basel). 2004, Vol 64, pp 1-5, issn 0012-6667, 5 p., SUP1Article

Antithrombin-heparin covalent complex: A possible alternative to heparin for arterial thrombosis preventionCHAN, Anthony K. C; RAK, Janusz; BERRY, Leslie et al.Circulation (New York, N.Y.). 2002, Vol 106, Num 2, pp 261-265, issn 0009-7322Article

Anticoagulants in heart disease : current status and perspectivesDE CATERINA, Raffaele; HUSTED, Steen; VERHEUGT, Freek W. A et al.European heart journal. 2007, Vol 28, Num 7, pp 880-913, issn 0195-668X, 34 p.Article

Antithrombotic therapy in patients undergoing percutaneous coronary interventionPOPMA, Jeffrey J; OHMAN, E. Magnus; WEITZ, Jeffrey et al.Chest. 2001, Vol 119, Num 1, pp 321S-336S, issn 0012-3692, SUPArticle

Emerging therapies for stroke prevention in atrial fibrillationO'DONNELL, Martin; AGNELLI, Giancarlo; WEITZ, Jeffrey I et al.European heart journal supplements. 2005, Vol 7, Num C, pp C19-C27, issn 1520-765XArticle